Jasbir Seehra's Net Worth

$13 Million

Estimate Recalculated Nov 11, 2024 08:46AM EST

Who is Jasbir Seehra?

Jasbir Seehra has an estimated net worth of $13 Million. This is based on reported shares across multiple companies, which include Keros Therapeutics, Inc., and Eloxx Pharmaceuticals, Inc..

SEC CIK

Jasbir Seehra's CIK is 0001732369

Past Insider Trading and Trends

2020 was Jasbir Seehra's most active year for acquiring shares with 4 total transactions. Jasbir Seehra's most active month to acquire stocks was the month of March. 2020 was Jasbir Seehra's most active year for disposing of shares, totalling 1 transactions. Jasbir Seehra's most active month to dispose stocks was the month of March. 2020 saw Jasbir Seehra paying a total of $320,000.00 for 747,738 shares, this is the most they've acquired in one year. In 2020 Jasbir Seehra cashed out on 11,169 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Keros Therapeutics, Inc. (KROS) Snapshot price: $52.51

CHIEF EXECUTIVE OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 23
Form 4
—
0
—
—
0
Feb 13
Form 4
+1.61%
4K
$0.48
$1,920.00
252.86K
Apr 8
Form 4
—
0
—
—
0
Feb 16
Form 4
+2.05%
5K
$0.30
$1,500.00
248.86K
Jun 9
Form 4
—
0
—
—
0
Jan 21
Form 4
—
0
—
—
0
Jan 10
Form 4
+14.65%
31.17K
$16.00
—
243.86K
Apr 13
Form 4
—
0
—
—
0
Apr 7
Form 3
—
0
—
—
0
No matching records found

Eloxx Pharmaceuticals, Inc. (ELOX) Snapshot price: $0.82

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
Jun 15
Form 3
—
0
—
—
0
No matching records found